Related Experiment Video
Updated: Apr 3, 2026

Establishment of Rat Models Mimicking Gender-affirming Hormone Therapies
Published on: January 10, 2025
Hormone Replacement Therapy, Likely Neither Angel Nor Demon
Mitchell S Wachtel1, Shengping Yang1, Sharmila Dissanaike2
1Department of Pathology, Texas Tech University Health Sciences Center, Lubbock, Texas, United States of America.
Hormone replacement therapy (HRT) prescription rates declined significantly after 2001, but this trend does not explain changes in breast cancer incidence rates. The study found no general effect of HRT on other major health conditions.
Area of Science:
- Oncology
- Epidemiology
- Public Health
Background:
- Hormone replacement therapy (HRT) use has been linked to breast cancer incidence, with a notable decline in prescriptions following the 2003 Women's Health Initiative (WHI) paper.
- Previous analyses have not comprehensively evaluated HRT prescription trends against breast cancer incidence over extended periods.
Purpose of the Study:
- To analyze the relationship between hormone replacement therapy (HRT) prescription rates and breast cancer incidence using extensive Surveillance, Epidemiology, and End Results (SEER) data.
- To investigate potential associations between declining HRT use and the incidence of other health conditions, including cardiovascular diseases and fractures.
Main Methods:
- Utilized SEER data (1992-2012) for breast and endometrial carcinoma incidence rates in women over 50.
- Incorporated data from the Medical Expenditure Panel Survey (1996-2012) for HRT prescription trends and the National Hospital Discharge Survey (1996-2010) for major health event incidence.
- Applied Joinpoint regression analysis to evaluate trends and changes in incidence rates over time.
Main Results:
- HRT prescription rates decreased significantly from 2001 to 2012 (AAPC -14.9%).
- Breast cancer rates, after an initial decline, showed an increase post-2003, with rates in 2012 similar to 2001 levels for both ductal and lobular carcinomas.
- Endometrial carcinoma rates increased during the study period, and no significant differences in the trends of femoral neck fractures, hip replacements, myocardial infarctions, or cerebral infarctions were detected across genders, suggesting no general HRT effect.
Conclusions:
- Changes in breast cancer incidence rates cannot be attributed to the observed shifts in hormone replacement therapy (HRT) prescription patterns.
- The study did not find evidence to support a general association between HRT discontinuation and the incidence of major health conditions like cardiovascular events or fractures.
More Related Videos
Related Concept Videos
Target Cell Response to Hormones
Notably, the cellular response can be regulated by altering the number of receptors expressed in the cell. For example, prolonged exposure to elevated hormone levels results in a gradual decline or down-regulation in the number of receptors for that specific hormone on the cell surface. Conversely, in response to low hormone levels, cells may use up-regulation, producing an...
Intracellular Hormone Receptors
Major Hormones and Their Functions
Oxytocin, produced in the hypothalamus and released by the pituitary gland, plays a role in social bonding, childbirth, and...
Hormonal Regulation
Hormonal Regulation
Hormonal Regulation of the Menstrual Cycle
At puberty, GnRH begins a pulsatile release pattern, which triggers the anterior pituitary gland to secrete follicle-stimulating hormone (FSH) and luteinizing hormone (LH). The frequency and amplitude of GnRH pulses vary across the menstrual cycle, with faster pulses favoring LH release and slower pulses favoring FSH...

